Urgent: Italians Urged to not Purchase and to not Use Novartis Influenza Vaccines (Min. of Health, October 24 2012, edited)

[Giuseppe]

[Source: Italy Ministry of Health, full page in Italian: (LINK). Translated, edited.]

Urgent: Citizens Urged to not Purchase and to not Use Novartis Influenza Vaccines

Press Release n. 216 ? October 24 2012



The Ministry of Health and Italian Agency for Drugs Safety (AIFA) ordered the immediate precautionary interdiction to use the following seasonal influenza vaccines, until further investigations will be done:

1. Agrippal;
2. Influpozzi sub-unit;
3. Influpozzi adjuvanted;
4. Fluad.

Concerned citizens are urged to not purchase and to not use the above vaccines until a new pronouncement by the Ministry of Health.

The interdicted vaccines have been made by Novartis company.

The AIFA, on the basis of the documentation presented by the company, ordered additional investigations on the quality and safety of such vaccines, because of the possible increased reactogenicity of them, or their ability to cause adverse reactions and side effects.

The Minister of Health, professor Renato Balduzzi, is closely following the situation. Further details will be available later this day.

-
------

[Emily]

Re: Norvartis Vaccines Quality Issue: press conference with Italian Health Minister prof. Balduzzi, 5,45pm (Health Min., October 24 2012, edited)

http://www.fiercepharma.com/story/it...ety/2012-10-24

Italy bans Novartis vaccines even after company assures their safety
Johnson & Johnson withholds its flu vaccine for tests on quality
October 24, 2012 | By Eric Palmer
taly is having a difficult time getting flu vaccine. Italian authorities today said they are banning four different Novartis ($NVS) vaccines because of questions over "side effects" less than two weeks after being told by Johnson & Johnson ($JNJ) vaccine unit Crucell that its flu vaccine was being withheld over quality concerns...

Read more: Italy bans Novartis vaccines even after company assures their safety - FiercePharma http://www.fiercepharma.com/story/it...#ixzz2AGQwZveK